S-1 monotherapy
Sponsors
Chube Clinical Oncology Group (CCOG), Chinese PLA General Hospital
Conditions
Cancer of PancreasColorectal cancer
Phase 2
Multicenter phase II study of oral S-1 monotherapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapies
Active, not recruitingJPRN-UMIN000006487
Start: 2011-10-01Target: 34Updated: 2025-07-18
Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients
NCT03278015
Start: 2017-10-01End: 2018-09-30Target: 90Updated: 2017-09-11